Cargando…
Identification of Candidate Genes and Therapeutic Agents for Light Chain Amyloidosis Based on Bioinformatics Approach
OBJECTIVE: Systemic amyloid light chain (AL) amyloidosis is a rare plasma cell disease. However, the regulatory mechanisms of AL amyloidosis have not been thoroughly uncovered, identification of candidate genes and therapeutic agents for this disease is crucial to provide novel insights into explori...
Autores principales: | Bai, Wenxiang, Wang, Honghua, Bai, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997413/ https://www.ncbi.nlm.nih.gov/pubmed/32099441 http://dx.doi.org/10.2147/PGPM.S228574 |
Ejemplares similares
-
Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis
por: Morgan, Gareth J., et al.
Publicado: (2021) -
Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2018) -
Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis
por: Kolur, Vijayakrishna, et al.
Publicado: (2021) -
Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis
por: Zhang, Kathleen W., et al.
Publicado: (2019) -
Immunoglobulin Light-Chain Amyloidosis: Clinical Presentations and Diagnostic Approach
por: Hwa, Yi L., et al.
Publicado: (2019)